Valosin-containing protein (VCP)-adaptor interactions are exceptionally dynamic and subject to differential modulation by a VCP inhibitor

Molecular and Cellular Proteomics

Volumn 15, Issue 9, 2016, Pages 2970-2986

  Xue, Liang ^a   Blythe, Emily E ^a   Freiberger, Elyse C ^b   Mamrosh, Jennifer L ^a   Hebert, Alexander S ^c   Reitsma, Justin M ^a   Hess, Sonja ^d   Coon, Joshua J ^b,c   Deshaies, Raymond J ^a,e  

^a California Institute of Technology   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATASE INHIBITOR; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; NMS 873; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN; ADENOSINE TRIPHOSPHATASE; CDC48 PROTEIN; CELL CYCLE PROTEIN; PROTEIN BINDING; PROTEOME;

ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; HEK293 CELL LINE; HUMAN; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIZE EXCLUSION CHROMATOGRAPHY; CELL CULTURE; ENZYME SPECIFICITY; FIBROBLAST; METABOLISM; PROCEDURES;

ADENOSINE TRIPHOSPHATASES; CELL CYCLE PROTEINS; CELLS, CULTURED; CHROMATOGRAPHY, GEL; FIBROBLASTS; HEK293 CELLS; HUMANS; MASS SPECTROMETRY; PROTEIN BINDING; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; SUBSTRATE SPECIFICITY;

EID: 84989172871     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M116.061036     Document Type: Article

References (68)

1. Balch, W. E., Morimoto, R. I., Dillin, A., and Kelly, J. W. (2008) Adapting proteostasis for disease intervention. Science 319, 916-919
2. Bukau, B., Weissman, J., and Horwich, A. (2006) Molecular chaperones and protein quality control. Cell 125, 443-451
3. Doyle, S. M., Genest, O., and Wickner, S. (2013) Protein rescue from aggregates by powerful molecular chaperone machines. Nat. Rev. Mol. Cell Biol. 14, 617-629
4. Goldberg, A. L. (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895-899
5. Luo, J., Solimini, N. L., and Elledge, S. J. (2009) Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136, 823-837
6. Santaguida, S., and Amon, A. (2015) Short- and long-term effects of chromosome mis-segregation and aneuploidy. Nat. Rev. Mol. Cell Biol. 16, 473-485
7. Arias, E., and Cuervo, A. M. (2011) Chaperone-mediated autophagy in protein quality control. Curr. Opin. Cell Biol. 23, 184-189
8. Deshaies, R. J. (2014) Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy. BMC Biol. 12, 94
9. Teicher, B. A., and Anderson, K. C. (2015) CCR 20th anniversary commentary: In the beginning, there was PS-341. Clin. Cancer Res. 21, 939-941
10. Verma, R., Oania, R. S., Kolawa, N. J., and Deshaies, R. J. (2013) Cdc48/ p97 promotes degradation of aberrant nascent polypeptides bound to the ribosome. eLife 2, e00308
11. Brandman, O., Stewart-Ornstein, J., Wong, D., Larson, A., Williams, C. C., Li, G. W., Zhou, S., King, D., Shen, P. S., Weibezahn, J., Dunn, J. G., Rouskin, S., Inada, T., Frost, A., and Weissman, J. S. (2012) A ribosomebound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell 151, 1042-1054
12. Defenouillere, Q., Yao, Y., Mouaikel, J., Namane, A., Galopier, A., Decourty, L., Doyen, A., Malabat, C., Saveanu, C., Jacquier, A., and Fromont-Racine, M. (2013) Cdc48-associated complex bound to 60S particles is required for the clearance of aberrant translation products. Proc. Natl. Acad. Sci. U.S.A. 110, 5046-5051
13. Taylor, E. B., and Rutter, J. (2011) Mitochondrial quality control by the ubiquitin-proteasome system. Biochem. Soc. Trans. 39, 1509-1513
14. Ye, Y., Meyer, H. H., and Rapoport, T. A. (2001) The AAA ATPase Cdc48/ p97 and its partners transport proteins from the ER into the cytosol. Nature 414, 652-656
15. Meyer, H., and Weihl, C. C. (2014) The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. J. Cell Sci. 127, 3877-3883
16. Medicherla, B., and Goldberg, A. L. (2008) Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins. J. Cell Biol. 182, 663-673
17. Ju, J. S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H., and Weihl, C. C. (2009) Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 187, 875-888
18. Tresse, E., Salomons, F. A., Vesa, J., Bott, L. C., Kimonis, V., Yao, T. P., Dantuma, N. P., and Taylor, J. P. (2010) VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6, 217-227
19. Buchan, J. R., Kolaitis, R. M., Taylor, J. P., and Parker, R. (2013) Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 153, 1461-1474
20. Ju, J. S., Miller, S. E., Hanson, P. I., and Weihl, C. C. (2008) Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/ VCP-associated disease. J. Biol. Chem. 283, 30289-30299
21. Alexandru, G., Graumann, J., Smith, G. T., Kolawa, N. J., Fang, R., and Deshaies, R. J. (2008) UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell 134, 804-816
22. Buchberger, A., Schindelin, H., and Hanzelmann, P. (2015) Control of p97 function by cofactor binding. FEBS Lett. 589, 2578-2589
23. Raman, M., Sergeev, M., Garnaas, M., Lydeard, J. R., Huttlin, E. L., Goessling, W., Shah, J. V., and Harper, J. W. (2015) Systematic proteomics of the VCP-UBXD adaptor network identifies a role for UBXN10 in regulating ciliogenesis. Nat. Cell Biol. 17, 1356-1369
24. Schuberth, C., and Buchberger, A. (2008) UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97. Cell Mol. Life Sci. 65, 2360-2371
25. Elsasser, S., and Finley, D. (2005) Delivery of ubiquitinated substrates to protein-unfolding machines. Nat. Cell Biol. 7, 742-749
26. Verma, R., Oania, R., Fang, R., Smith, G. T., and Deshaies, R. J. (2011) Cdc48/p97 mediates UV-dependent turnover of RNA Pol II. Mol. Cell 41, 82-92
27. Riemer, A., Dobrynin, G., Dressler, A., Bremer, S., Soni, A., Iliakis, G., and Meyer, H. (2014) The p97-Ufd1-Npl4 ATPase complex ensures robustness of the G2/M checkpoint by facilitating CDC25A degradation. Cell Cycle 13, 919-927
28. Ritz, D., Vuk, M., Kirchner, P., Bug, M., Schutz, S., Hayer, A., Bremer, S., Lusk, C., Baloh, R. H., Lee, H., Glatter, T., Gstaiger, M., Aebersold, R., Weihl, C. C., and Meyer, H. (2011) Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations. Nat. Cell Biol. 13, 1116-1123
29. He, J., Zhu, Q., Wani, G., Sharma, N., and Wani, A. A. (2016) VCP/p97 Segregase Mediates Proteolytic Processing of CSB in Damaged Chromatin. J. Biol. Chem. 291, 7396-708
30. Jentsch, S., and Rumpf, S. (2007) Cdc48 (p97): a "molecular gearbox" in the ubiquitin pathway? Trends Biochem. Sci. 32, 6-11
31. Chou, T. F., Brown, S. J., Minond, D., Nordin, B. E., Li, K., Jones, A. C., Chase, P., Porubsky, P. R., Stoltz, B. M., Schoenen, F. J., Patricelli, M. P., Hodder, P., Rosen, H., and Deshaies, R. J. (2011) A reversible inhibitor of the AAA ATPase p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways. Proc. Natl. Acad. Sci. U.S.A. 108, 4834- 4839
32. Magnaghi, P., D'Alessio, R., Valsasina, B., Avanzi, N., Rizzi, S., Asa, D., Gasparri, F., Cozzi, L., Cucchi, U., Orrenius, C., Polucci, P., Ballinari, D., Perrera, C., Leone, A., Cervi, G., Casale, E., Xiao, Y., Wong, C., Anderson, D. J., Galvani, A., Donati, D., O'Brien, T., Jackson, P. K., and Isacchi, A. (2013) Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat. Chem. Biol. 9, 548-556
33. Acharya, P., Liao, M., Engel, J. C., and Correia, M. A. (2011) Liver cytochrome P450 3A endoplasmic reticulum-associated degradation: a major role for the p97 AAA ATPase in cytochrome p450 3A extraction into the cytosol. J. Biol. Chem. 286, 3815-3828
34. Piccirillo, R., and Goldberg, A. L. (2012) The p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteins. EMBO J. 31, 3334-3350
35. Chou, T. F., Li, K., Frankowski, K. J., Schoenen, F. J., and Deshaies, R. J. (2013) Structure-activity relationship study reveals ML240 and ML241 as potent and selective inhibitors of p97 ATPase. Chem. Med. Chem. 8, 297-312
36. Zhou, H. J., Wang, J., Yao, B., Wong, S., Djakovic, S., Kumar, B., Rice, J., Valle, E., Soriano, F., Menon, M. K., Madriaga, A., Kiss von Soly, S., Kumar, A., Parlati, F., Yakes, F. M., Shawver, L., Le Moigne, R., Anderson, D. J., Rolfe, M., and Wustrow, D. (2015) Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083). J. Med. Chem. 58, 9480-9497
37. Anderson, D. J., Le Moigne, R., Djakovic, S., Kumar, B., Rice, J., Wong, S., Wang, J., Yao, B., Valle, E., Kiss von Soly, S., Madriaga, A., Soriano, F., Menon, M. K., Wu, Z. Y., Kampmann, M., Chen, Y., Weissman, J. S., Aftab, B. T., Yakes, F. M., Shawver, L., Zhou, H. J., Wustrow, D., and Rolfe, M. (2015) Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis. Cancer Cell 28, 653- 665
38. Chou, T. F., Bulfer, S. L., Weihl, C. C., Li, K., Lis, L. G., Walters, M. A., Schoenen, F. J., Lin, H. J., Deshaies, R. J., and Arkin, M. R. (2014) Specific Inhibition of p97/VCP ATPase and Kinetic Analysis Demonstrate Interaction between D1 and D2 ATPase domains. J. Mol. Biol. 426, 2886-2899
39. Yu, C. C., Yang, J. C., Chang, Y. C., Chuang, J. G., Lin, C. W., Wu, M. S., and Chow, L. P. (2013) VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells. PLoS ONE 8, e55724
40. Szymczak, A. L., Workman, C. J., Wang, Y., Vignali, K. M., Dilioglou, S., Vanin, E. F., and Vignali, D. A. (2004) Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22, 589-594
41. Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., and Zhang, F. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819- 823
42. Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., and Zhang, F. (2013) Genome engineering using the CRISPR-Cas9 system. Nat. Protocols 8, 2281-2308
43. Stark, C., Breitkreutz, B. J., Reguly, T., Boucher, L., Breitkreutz, A., and Tyers, M. (2006) BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 34, D535-D539
44. Bruderer, R. M., Brasseur, C., and Meyer, H. H. (2004) The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism. J. Biol. Chem. 279, 49609- 49616
45. Yin, J., Lin, A. J., Golan, D. E., and Walsh, C. T. (2006) Site-specific protein labeling by Sfp phosphopantetheinyl transferase. Nat. Protocols 1, 280-285
46. Kirkwood, K. J., Ahmad, Y., Larance, M., and Lamond, A. I. (2013) Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol. Cell. Proteomics 12, 3851-3873
47. Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., and Zhang, F. (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84-87
48. Wang, X., and Huang, L. (2008) Identifying dynamic interactors of protein complexes by quantitative mass spectrometry. Mol. Cell. Proteomics 7, 46-57
49. Mann, M. (2006) Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 7, 952-958
50. Chia, W. S., Chia, D. X., Rao, F., Bar Nun, S., and Geifman Shochat, S. (2012) ATP binding to p97/VCP D1 domain regulates selective recruitment of adaptors to its proximal N-domain. PLoS ONE 7, e50490
51. Dreveny, I., Kondo, H., Uchiyama, K., Shaw, A., Zhang, X., and Freemont, P. S. (2004) Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47. EMBO J. 23, 1030-1039
52. Beuron, F., Dreveny, I., Yuan, X., Pye, V. E., McKeown, C., Briggs, L. C., Cliff, M. J., Kaneko, Y., Wallis, R., Isaacson, R. L., Ladbury, J. E., Matthews, S. J., Kondo, H., Zhang, X., and Freemont, P. S. (2006) Conformational changes in the AAA ATPase p97-p47 adaptor complex. EMBO J. 25, 1967-1976
53. Hanzelmann, P., Buchberger, A., and Schindelin, H. (2011) Hierarchical binding of cofactors to the AAA ATPase p97. Structure 19, 833-843
54. Zhang, X., Gui, L., Zhang, X., Bulfer, S. L., Sanghez, V., Wong, D. E., Lee, Y., Lehmann, L., Lee, J. S., Shih, P. Y., Lin, H. J., Iacovino, M., Weihl, C. C., Arkin, M. R., Wang, Y., and Chou, T. F. (2015) Altered cofactor regulation with disease-associated p97/VCP mutations. Proc. Natl. Acad. Sci. U.S.A. 112, E1705-E1714
55. Her, N. G., Toth, J. I., Ma, C. T., Wei, Y., Motamedchaboki, K., Sergienko, E., and Petroski, M. D. (2016) p97 Composition Changes Caused by Allosteric Inhibition Are Suppressed by an On-Target Mechanism that Increases the Enzyme's ATPase Activity. Cell Chem. Biol. 23, 517-528
56. Song, C., Wang, Q., and Li, C. C. (2003) ATPase activity of p97-valosincontaining protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J. Biol. Chem. 278, 3648-3655
57. Niwa, H., Ewens, C. A., Tsang, C., Yeung, H. O., Zhang, X., and Freemont, P. S. (2012) The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP. J. Biol. Chem. 287, 8561- 8570
58. DeLaBarre, B., Christianson, J. C., Kopito, R. R., and Brunger, A. T. (2006) Central pore residues mediate the p97/VCP activity required for ERAD. Mol. Cell 22, 451-462
59. Meyer, H. H., Kondo, H., and Warren, G. (1998) The p47 co-factor regulates the ATPase activity of the membrane fusion protein, p97. FEBS Lett. 437, 255-257
60. Kondo, H., Rabouille, C., Newman, R., Levine, T. P., Pappin, D., Freemont, P., and Warren, G. (1997) p47 is a cofactor for p97-mediated membrane fusion. Nature 388, 75-78
61. Mori-Konya, C., Kato, N., Maeda, R., Yasuda, K., Higashimae, N., Noguchi, M., Koike, M., Kimura, Y., Ohizumi, H., Hori, S., and Kakizuka, A. (2009) p97/valosin-containing protein (VCP) is highly modulated by phosphorylation and acetylation. Genes Cells 14, 483- 497
62. Uchiyama, K., Jokitalo, E., Lindman, M., Jackman, M., Kano, F., Murata, M., Zhang, X., and Kondo, H. (2003) The localization and phosphorylation of p47 are important for Golgi disassembly-assembly during the cell cycle. J. Cell Biol. 161, 1067-1079
63. Orme, C. M., and Bogan, J. S. (2012) The ubiquitin regulatory X (UBX) domain-containing protein TUG regulates the p97 ATPase and resides at the endoplasmic reticulum-golgi intermediate compartment. J. Biol. Chem. 287, 6679-6692
64. Belman, J. P., Habtemichael, E. N., and Bogan, J. S. (2014) A proteolytic pathway that controls glucose uptake in fat and muscle. Rev. Endocr. Metab. Disord. 15, 55-66
65. Sane, S., Abdullah, A., Boudreau, D. A., Autenried, R. K., Gupta, B. K., Wang, X., Wang, H., Schlenker, E. H., Zhang, D., Telleria, C., Huang, L., Chauhan, S. C., and Rezvani, K. (2014) Ubiquitin-like (UBX)-domaincontaining protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells. Cell Death Dis. 5, e1118
66. Rezvani, K., Teng, Y., Pan, Y., Dani, J. A., Lindstrom, J., Garcia Gras, E. A., McIntosh, J. M., and De Biasi, M. (2009) UBXD4, a UBX-containing protein, regulates the cell surface number and stability of alpha3-containing nicotinic acetylcholine receptors. J. Neurosci. 29, 6883- 6896
67. Chou, T. F., and Deshaies, R. J. (2011) Development of p97 AAA ATPase inhibitors. Autophagy 7, 1091-1092
68. Vizcaino, J. A., Cote, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., O'Kelly, G., Schoenegger, A., Ovelleiro, D., Perez-Riverol, Y., Reisinger, F., Rios, D., Wang, R., and Hermjakob, H. (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-D1069